This excerpt taken from the TPTX 8-K filed Oct 10, 2006.
3.3 Disclosure of Licensed Know-How. LSRI shall use commercially reasonable efforts to supply Neurogenetics, as promptly as practicable after the Effective Date, and in any event within [***] ([***]) days of the Effective Date, with all Licensed Know-How. The parties agree to work in good faith to complete the provision of Licensed Know-How to Neurogenetics within the time period set forth above. In addition, during such period, LSRI will grant Neurogenetics access, during normal business hours, to appropriate LSRI personnel for reasonable consultation related to the Licensed Know-How in accordance with LSRIs regulations. Neurogenetics will pay LSRI for the reasonable cost of such disclosure. LSRI will provide Neurogenetics with reasonable documentation regarding such costs at the time it provides an invoice for payment.